Published in J Infect Dis on February 01, 1997
Serotype-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residues at positions of codon degeneracy. J Clin Microbiol (1998) 1.93
Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range. J Virol (2008) 1.85
The risks, costs, and benefits of possible future global policies for managing polioviruses. Am J Public Health (2008) 0.94
Geographic distribution of wild poliovirus type 1 genotypes. Virology (1987) 4.03
Handwashing to prevent diarrhea in day-care centers. Am J Epidemiol (1981) 3.75
Genetic co-regulation of galactose and melibiose utilization in Saccharomyces. J Bacteriol (1976) 2.92
Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet (1991) 2.64
Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans. Virology (1981) 2.64
Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis (1992) 2.55
Multiple genetic changes can occur in the oral poliovaccines upon replication in humans. J Gen Virol (1981) 2.54
Measles vaccination and Guillain-Barré syndrome. Lancet (1997) 2.36
Detection and identification of vaccine-related polioviruses by the polymerase chain reaction. Virus Res (1991) 2.35
Genotype-specific in vitro amplification of sequences of the wild type 3 polioviruses from Mexico and Guatemala. Virus Res (1992) 2.33
Deterrents to well-child supervision. Am J Public Health Nations Health (1966) 2.33
Protein processing map of poliovirus. J Virol (1984) 2.33
Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984. JAMA (1987) 2.28
Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy. J Clin Microbiol (1996) 2.23
Immune status of children one to four years of age as determined by history and antibody measurement. N Engl J Med (1973) 2.06
Parameters for differentiating vaccine-derived and wild poliovirus strains. Prog Med Virol (1978) 1.96
Strategies for the global eradication of poliomyelitis by the year 2000. N Engl J Med (1991) 1.92
Changes in three of the four coat proteins of oral polio vaccine strain derived from type 1 poliovirus. J Virol (1980) 1.91
Epidemic viral hepatitis, type B, in hospital personnel. Am J Med (1974) 1.87
Comparative study of five methods for intratypic differentiation of polioviruses. J Clin Microbiol (1995) 1.83
Picornaviral VPg sequences are contained in the replicase precursor. J Virol (1980) 1.77
Reovirus-like agent as a cause of nosocomial diarrhea in infants. J Pediatr (1977) 1.73
The case for global eradication of poliomyelitis. Bull World Health Organ (1987) 1.72
Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China. J Virol (2000) 1.71
Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model. J Virol (2000) 1.54
Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication. Int J Epidemiol (2001) 1.53
An outbreak of hepatitis-A associated with recreational lake water. Am J Epidemiol (1974) 1.51
Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel. J Clin Microbiol (2000) 1.50
Epidemiologic study of Guillain-Barré syndrome in children <15 years of age in Latin America. J Infect Dis (1997) 1.33
The surveillance challenge: final stages of eradication of poliomyelitis in the Americas. MMWR CDC Surveill Summ (1992) 1.27
Viruses isolated from children with infectious hepatitis. Am J Epidemiol (1966) 1.26
Mouse neurovirulence determinants of poliovirus type 1 strain LS-a map to the coding regions of capsid protein VP1 and proteinase 2Apro. J Virol (1994) 1.25
Resolution of the pathways of poliovirus type 1 transmission during an outbreak. J Clin Microbiol (2000) 1.23
Eradication of wild poliovirus from the Americas: acute flaccid paralysis surveillance, 1988-1995. J Infect Dis (1997) 1.22
Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies. Bull World Health Organ (1994) 1.20
Direct detection of wild poliovirus circulation by stool surveys of healthy children and analysis of community wastewater. J Infect Dis (1993) 1.19
Molecular epidemiology of wild poliovirus type 1 in Europe, the Middle East, and the Indian subcontinent. J Infect Dis (1995) 1.18
Failure to detect an antigen associated with hepatitis in a community epidemic. Nature (1970) 1.16
Monoclonal antibodies of four different specificities for neutralization of type 1 polioviruses. Infect Immun (1982) 1.14
Review of regional measles surveillance data in the Americas, 1996-99. Lancet (2000) 1.13
Amyotrophic lateral sclerosis with antecedent poliomyelitis. Arch Neurol (1980) 1.13
Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection. Am J Epidemiol (1994) 1.09
Certification of the eradication of indigenous transmission of wild poliovirus in the Americas. J Infect Dis (1997) 1.07
Strategies to eradicate rubella in the English-speaking Caribbean. Am J Public Health (2000) 1.05
Alienation as a deterrent to well-child supervision. Am J Public Health Nations Health (1966) 1.04
Oligonucleotide probes for the specific detection of the wild poliovirus types 1 and 3 endemic to Brazil. Intervirology (1991) 1.04
Molecular epidemiology of polioviruses. Rev Infect Dis (1984) 1.01
Coupled mutations in the 5'-untranslated region of the Sabin poliovirus strains during in vivo passages: structural and functional implications. Virus Res (1991) 0.99
Oligonucleotide fingerprint analysis of enterovirus 70 isolates from the 1980 to 1981 pandemic of acute hemorrhagic conjunctivitis: evidence for a close genetic relationship among Asian and American strains. Infect Immun (1983) 0.99
Poliomyelitis in the USA: virtual elimination of disease caused by wild virus. Lancet (1984) 0.99
Acute hemorrhagic conjunctivitis Investigation of a large-scale community outbreak in Dade County, Florida. JAMA (1983) 0.98
Distribution of wild type 1 poliovirus genotypes in China. J Infect Dis (1993) 0.96
Molecular characterization of a wild poliovirus type 3 epidemic in The Netherlands (1992 and 1993). J Clin Microbiol (1995) 0.94
Geographical genotypes (geotypes) of poliovirus case isolates from the former Soviet Union: relatedness to other known poliovirus genotypes. J Gen Virol (1995) 0.93
Nonparenteral serum hepatitis. Report of an outbreak. JAMA (1972) 0.93
Gianotti-Crosti-like eruption associated with coxsackievirus A-16 infection. J Am Acad Dermatol (1982) 0.93
Vaccine-associated poliomyelitis in a child with sex-linked agammaglobulinemia. J Pediatr (1977) 0.93
Rational use of rubella vaccine for prevention of congenital rubella syndrome in the Americas. Rev Panam Salud Publica (1998) 0.92
The effect of immune globulin on the response to trivalent oral poliovirus and yellow fever vaccinations. Bull World Health Organ (1984) 0.92
Aseptic meningitis and high school football players. 1978 and 1980. JAMA (1983) 0.92
Hemolytic-uremic syndrome--an outbreak in Sacramento, California. West J Med (1986) 0.91
Natural variants of the Sabin type 1 vaccine strain of poliovirus and correlation with a poliovirus neutralization site. Virology (1985) 0.91
Acute enteritis associated with reovirus-like agents. JAMA (1976) 0.90
Preparation of glutamate dehydrogenase from Micrococcus aerogenes. Biochem Biophys Res Commun (1970) 0.90
Risk of vaccine-associated paralytic poliomyelitis in Latin America, 1989-91. Bull World Health Organ (1995) 0.89
A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases. Am J Public Health (1989) 0.89
Isolation of enterovirus 70 from patients with acute hemorrhagic conjunctivitis in Key West, Florida. N Engl J Med (1981) 0.88
Modified counterelectrophoresis method for subtyping hepatitis B antigen. J Clin Microbiol (1975) 0.87
Genetic heterogeneity of the attachment glycoprotein G among group A respiratory syncytial viruses. Virus Res (1994) 0.87
Regions of poliovirus protein VP1 produced in Escherichia coli induce neutralizing antibodies. J Virol (1987) 0.87
Biophysical properties of a non-cultivable 29-nm enteric virus. J Gen Virol (1979) 0.87
National immunization days: experience in Latin America. J Infect Dis (1997) 0.86
The 2010 outbreak of poliomyelitis in Tajikistan: epidemiology and lessons learnt. Euro Surveill (2014) 0.86
Poliomyelitis in the United States, 1969-1981. J Infect Dis (1982) 0.86
[Self-medication profile in a city of south Brazil]. Rev Saude Publica (1998) 0.85
Neonatal tetanus: countdown to 1995. World Health Forum (1991) 0.84
Measles eradication: experience in the Americas. Bull World Health Organ (1998) 0.84
Global eradication of poliomyelitis and measles: another quiet revolution. Ann Intern Med (1997) 0.84
Molecular detection of an importation of type 3 wild poliovirus into Canada from The Netherlands in 1993. Appl Environ Microbiol (1997) 0.83
Outbreak of poliomyelitis in Gizan, Saudi Arabia: cocirculation of wild type 1 polioviruses from three separate origins. J Infect Dis (1997) 0.83
Trivalent oral poliovirus vaccine: a comparison of two infant immunization schedules. Pediatrics (1970) 0.82
Isolation of echoviruses with human embryonic lung fibroblast cells. Appl Microbiol (1971) 0.81
Intradermal administration of measles vaccines. Bull Pan Am Health Organ (1994) 0.81
Acute hemorrhagic conjunctivitis in Puerto Rico, 1981-1982. Am J Epidemiol (1984) 0.81
Complement fixation reactions between adenovirus antigens and sera from infectious hepatitis cases. Proc Soc Exp Biol Med (1969) 0.79
[Eradication of measles in Cuba]. Rev Panam Salud Publica (1998) 0.78
Interactions of standard antibody with Australia antigens in Au Ag-Ab radioimmunoassay. Appl Microbiol (1974) 0.78
Aseptic meningitis among members of a high school football team. An outbreak associated with echovirus 16 infection. JAMA (1982) 0.78
Application of the polymerase chain reaction (PCR) to poliomyelitis surveillance through the analyses of sewage samples. World J Microbiol Biotechnol (1993) 0.78
Human leukocyte interferon in the treatment and prophylaxis of acute hemorrhagic conjunctivitis. J Infect Dis (1984) 0.78
Detection of enterovirus 70 with monoclonal antibodies. J Clin Microbiol (1984) 0.78
Acute hemorrhagic conjunctivitis, Key West, Florida. An assessment of risk factors for introduction of illness into households and secondary spread during the 1981 epidemic. Am J Epidemiol (1984) 0.77
Quantitation of enterovirus 70 antibody by microneutralization test and comparison with standard neutralization, hemagglutination inhibition, and complement fixation tests with different virus strains. J Clin Microbiol (1984) 0.77
Acute hemorrhagic conjunctivitis caused by enterovirus type 70: an epidemic in American Samoa. Am J Trop Med Hyg (1985) 0.77
An outbreak of aseptic meningitis in the area of Fort Smith, Arkansas, 1975, due to echovirus type 4. J Ark Med Soc (1977) 0.76
[Poliomyelitis outbreak caused by vaccine-derived virus in Haiti and the Dominican Republic]. Rev Panam Salud Publica (2001) 0.76